Children Born With Club Feet (CBCF)

September 24, 2018 updated by: University Hospital, Montpellier

Children Born With Club Feet: Ultrasound Diagnosis and Antenatal Assessment

Clubfoot is one of the most common birth defects, with a prevalence in Europe estimated between 1 and 4.5 for 1000 live birth.

It is useful to distinguish the forms of isolated clubfoot, and the forms related to others morphological abnormalities (complex clubfoot). For the complex forms, the clubfoot can be integrated in a syndromic association, be the consequence of a serious harm of the central nervous system, be associate to a genetic musculo-skeletal disease or wether be associated to a karyotype abnormality.

In those cases, the prognosis depends more about the associated morphological abnormalities that can be the beginning of a severe disability or incompatible with life or any anomaly of the karyotype that clubfoot itself.

In case of several morphological abnormalities, to propose invasive samples with realization of a karyotype and chromosome analysis with CGH array is a consensual attitude.

What the investigators should recommended to the parents in case of isolated form is less obvious and the question of antenatal investigations can not be answered clearly in the literature. Thus, the management of these patients may vary from one CPDP to another.

This study project will make it possible to analyze the management offered to patients whose fetuses have club feet and to study the results of the various examinations carried out in order to adapt the prenatal counselling and to define the best diagnostic strategy to propose to the future parents.

Study Overview

Study Type

Observational

Enrollment (Actual)

219

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Uhmontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Infants with a clubfoot, antenatal diagned or not, treated at the " Institut Saint Pierre, Plavas-les-flots, France "

Description

Inclusion criteria:

  • Congenital clubfoot uni or bilateral
  • Have been treated in the reference center " Institut Saint Pierre, Plavas-les-flots, France "

Exclusion criteria:

- Non confirmed clubfoot after birth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Infants who are treated for clubfoot
Infants who are treated for clubfoot in the reference reeducation center
Invasive analysis (caryotype, CGH array)
Prenatal management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antenatal detection rate of clubfeet
Time Frame: At birth
Antenatal detection rate of clubfeet in percentage
At birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of isolated clubfoot among children followed for clubfoot
Time Frame: At birth
Rate of isolated clubfoot among children followed for clubfoot in percentage
At birth
Rate of refered for second-degree examination
Time Frame: At birth
Rate of refered for second-degree examination in percentage
At birth
Rate of invasive samples taken and their results
Time Frame: At birth
Rate of invasive samples taken and their results in percentage
At birth
Rate of files submitted to our reference center committee
Time Frame: At birth
Rate of files submitted to our reference center committee in percentage
At birth
Research rates of musculoskeletal genetic disease
Time Frame: At birth
Research rates of musculoskeletal genetic disease in percentage
At birth
Rate of consultation with geneticist
Time Frame: At birth
Rate of consultation with geneticist in percentage
At birth
Rate of consultation with a orthopedic surgeon
Time Frame: At birth
Rate of consultation with a orthopedic surgeon in percentage
At birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Florent FUCHS, PhD, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2014

Primary Completion (Actual)

August 31, 2018

Study Completion (Actual)

August 31, 2018

Study Registration Dates

First Submitted

September 10, 2018

First Submitted That Met QC Criteria

September 13, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

September 26, 2018

Last Update Submitted That Met QC Criteria

September 24, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clubfoot

Clinical Trials on Invasive analysis (caryotype, CGH array)

3
Subscribe